Century Health is partnering with the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University (VCU) to build an AI-powered clinical research database focused on steatotic liver disease (SLD). The initiative aims to generate large-scale, real-world evidence to better understand disease progression and outcomes across conditions such as MASLD, alcohol-related liver disease, and mixed etiologies.
The database will be powered by Century Health’s AI platform, which extracts both structured and unstructured data from electronic health records. Developed under VCU’s institutional oversight, the system will enable analysis of tens of thousands of patient records, capturing longitudinal disease trajectories, clinical outcomes, and key variables such as fibrosis, noninvasive biomarkers, and patterns of alcohol exposure. The dataset will expand over time as new research questions and variables are introduced.
Researchers say the platform will serve as a foundation for clinical and translational research, helping to address critical knowledge gaps in SLD. By combining large-scale longitudinal data with advanced analytics, the collaboration aims to improve disease characterization and support more targeted therapeutic development.
The project builds on Century Health’s broader strategy of creating AI-enabled real-world datasets across multiple disease areas, including kidney, respiratory, and neurodegenerative conditions. Since launching in 2024, the company has formed several partnerships to convert clinical data into research-grade insights for drug development and care optimization.
Click here to read the original news story.
